StockFin.ai
NewsScreensInsightsPricing
/
Sign inTry Free
SF
New ChatNewsInsightsScreenerPricing
Sign In
NewsScreensChatSign In

Tools

Search Companies
News & Filings
Insights & Articles
FeaturesComing Soon
Pricing
Home โ€บ ALKYLAMINE

Alkyl Amines Chemicals Ltd (ALKYLAMINE)

Chemicals ยท Chemicals ยท NSE ยท Updated 29 September 2026
By StockFin Research Teamโ€ขAI-Assisted Analysisโ€ขSource: BSE/NSE Filings
โ‚น1,797.7โ†“ 7.21% (1Y)

๐ŸŽฏ Key Takeaways

  • Alkyl Amines Chemicals Ltd is in a stable growth phase, characterized by consistent revenue expansion and strong profitability metrics, supported by leadership continuity and conservative capital structure. Management has institutionalized executive succession through formal re-designations and profit-linked incentives, signaling long-term governance discipline.
  • Revenue declined 8.6% QoQ to โ‚น235 in Q4FY20.
  • โš ๏ธ 1) Overreliance on cyclical chemical demand and commodity price volatility, particularly for acetonitrile and amines, which could pressure margins. 2)
Market Cap
โ‚น9,195
P/E Ratio
45.7
P/B Ratio
17.13
ROE
30.7%
ROCE
43.8%
Debt/Equity
0.09
Div Yield
1.11%
Promoter
72.0%
โœจ Ask AI About ALKYLAMINE๐Ÿ“Š Interactive Charts

๐Ÿ“– The Story

Alkyl Amines Chemicals Ltd is in a stable growth phase, characterized by consistent revenue expansion and strong profitability metrics, supported by leadership continuity and conservative capital structure. Management has institutionalized executive succession through formal re-designations and profit-linked incentives, signaling long-term governance discipline.

๐Ÿ“ฐ What's Happening

In Q1 FY26, revenue surged to โ‚น537.31 crores from โ‚น395.18 crores in the prior quarter, driven by operational expansion and favorable market conditions. The board approved the re-designation of Yogesh Kothari as Executive Chairman and appointed Kirat Patel and Suneet Kothari as Joint Managing Directors effective October 1, 2026, alongside Rakesh Goyal as Executive Director - Operations for five years starting April 1, 2027. Shareholders endorsed these changes via postal ballot in August 2026, along with approval of non-executive director commissions up to 1% of net profits for five years beginning FY27. These moves reflect a structured succession plan and alignment of director incentives with profitability.

Source: Stock Announcements

๐Ÿ“Š Quarterly Results (โ‚น Cr)

MetricJun 2019Sep 2019Dec 2019Mar 2020
Revenue266235257235
Operating Profit53516660
OPM %19.8%21.8%25.6%25.7%
Net Profit37556049
EPSโ‚น17.98โ‚น26.93โ‚น29.62โ‚น24.13

The company demonstrated robust top-line growth in Q1 FY26, with revenue increasing sequentially from โ‚น395.18 crores to โ‚น537.31 crores, accompanied by a healthy rise in profitability. Despite flat operating margins in earlier quarters, the current trajectory suggests improved operational leverage, supported by scale and possibly favorable raw material dynamics. The consistent EPS growth and high ROE/ROCE indicate strong capital efficiency, though margin pressure in prior quarters warrants monitoring of cost structures amid input price volatility.

๐Ÿ”ฎ Management Outlook & What's Next

Management has not provided explicit forward guidance on revenue or margin expectations in the latest filings. However, the board highlighted plans for capital expenditure, anti-dumping duty approval for acetonitrile, and remuneration ratification as part of ongoing strategic initiatives. The focus remains on sustaining growth through operational excellence and regulatory advantages, with future performance likely tied to execution of expansion plans and commodity cycle dynamics.

Extracted from official company announcements. Not StockFin.ai's opinion.

๐Ÿฆ Balance Sheet (โ‚น Cr)

ItemMar 2019Mar 2020Mar 2020
Equity Capital101010
Reserves369526442
Borrowings1304886
Total Liabilities763783766
Fixed Assets376423383
Investments16018
Total Assets763783766

The balance sheet remains exceptionally strong, with negligible debt (D/E of 0.09) and growing equity and reserves, reflecting a conservative capital structure. Total assets have risen steadily, indicating reinvestment of earnings rather than aggressive leverage. This financial prudence supports long-term resilience and flexibility for strategic investments or downturns, though the lack of debt capacity may limit large-scale acquisitions.

๐Ÿ’ฐ Cash Flow Statement (โ‚น Cr)

ItemMar 2020
Operating+188
Investing-41
Financing-135
Net Cash Flow+12

๐Ÿ‘ฅ Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters72.0%72.0%72.0%72.0%
FII3.4%3.5%3.5%3.5%
DII2.9%3.0%3.0%3.1%
Public17.5%17.3%17.3%17.2%
# Shareholders1,53,4511,49,3241,46,0281,42,625

Promoter holding remains stable near 72%, with slight fluctuations in institutional interest. FII ownership has modestly increased from 3.43% to 3.49% over recent quarters, while DII rose from 2.89% to 3.1%, suggesting growing confidence among foreign and domestic institutional investors. The expanding shareholder base (1,42,625 individuals) reflects retail participation, but no significant accumulation or exit signals are evident from the data.

โš–๏ธ Peer Comparison โ€” Chemicals

CompanyMCap (โ‚น Cr)P/EROCEROED/E
PIDILITIND1.53 L Cr57.633.4%โ€”0.01
SRF73,81034.115.6%โ€”0.36
LINDEINDIA52,81496.717.5%โ€”0.00
FLUOROCHEM48,77479.79.6%โ€”0.34
NAVINFLUOR43,25654.722.2%โ€”0.31
GODREJIND36,15330.89.2%โ€”4.57
HSCL33,80742.020.7%โ€”0.16
AETHER23,02997.713.8%โ€”0.08
DEEPAKNTR21,15527.015.3%โ€”0.26
CASTROLIND19,89118.776.2%โ€”0.00

๐Ÿ”— Peer Stock Analyses

PIDILITINDSRFLINDEINDIAFLUOROCHEMNAVINFLUOR

โš ๏ธ Risk Factors

1) Overreliance on cyclical chemical demand and commodity price volatility, particularly for acetonitrile and amines, which could pressure margins. 2) Regulatory exposure, as seen with anti-dumping duty approvals, which may face legal or geopolitical challenges. 3) Leadership transition risks despite re-designations, given the long-term nature of roles but potential execution gaps in new responsibilities. 4) Limited debt capacity may constrain growth financing in capital-intensive expansion phases.

๐Ÿ“‹ Recent Filings

  • Announcement2026-09-24Alkyl Amines Chemicals Ltd announced that its trading window will close on October 1, 2026, to facilitate disclosure of unaudited quarterly results enโ€ฆ
  • ๐Ÿ”ด Corporate Action2026-09-17Alkyl Amines Chemicals approved the allotment of 2,047 equity shares to eligible employees under its ESOP-2018 plan on September 17, 2026, increasing โ€ฆ
  • ๐ŸŸก voting results2026-08-18Alkyl Amines Chemicals Limited announced shareholder approval via postal ballot for key managerial appointments and compensation changes. Shareholdersโ€ฆ
  • ๐ŸŸก Board Meeting2026-08-04The board approved unaudited Q1 FY26 results showing revenue of **โ‚น537.31 crores**, up from **โ‚น395.18 crores** in Q4 FY26, and re-designated Yogesh Koโ€ฆ
  • ๐ŸŸก Board Meeting2026-08-04Alkyl Amines Chemicals announced board approval of unaudited Q1 FY26 results showing revenue of **โ‚น537.31 crores**, profit after tax of **โ‚น94.63 croreโ€ฆ
  • ๐ŸŸก Board Meeting2026-07-03Alkyl Amines Chemicals held its 46th AGM on July 3, 2026 via video conference, with Chairman Yogesh Kothari presiding. Shareholders approved the auditโ€ฆ
  • ๐ŸŸก Board Meeting2026-06-16The Board approved a circular resolution on June 16, 2026 to allot 2,125 equity shares of Rs. 2 each to eligible employees under the 2018 ESOP scheme,โ€ฆ
  • ๐Ÿ”ด annual report2026-06-09Alkyl Amines Chemicals Limited reported FY 2025-26 revenue of โ‚น1,51,188.46 lakhs, profit after tax of โ‚น17,999.91 lakhs, and declared a โ‚น10 per share dโ€ฆ
  • ๐Ÿ”ด annual report2026-06-09Alkyl Amines Chemicals Limited announced that it is dispatching the Annual Report for FY 2025-26 to shareholders whose email addresses are not registeโ€ฆ
  • ๐Ÿ”ด Announcement2026-06-05No summary available

๐Ÿง  Analyst's Read

Alkyl Amines Chemicals exhibits strong fundamentals and governance discipline, with growth underpinned by operational scale and favorable positioning in specialty chemicals. Investors should monitor execution of expansion plans, input cost trends, and any shifts in institutional sentiment, as the company navigates a maturing lifecycle with disciplined capital allocation.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights โ€” sign up free to unlock.

Sign Up Free โ€” Unlock Full Analysis

2 free AI queries per day.

โœจ Deep Dive with AI on ALKYLAMINE

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only โ€” not investment advice. Updated 2026-09-29.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

๐Ÿ“ก Get AI alerts when ALKYLAMINE files new disclosures

Track ALKYLAMINE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ALKYLAMINE โ€” Free

Free account ยท 2 AI queries/day

ยฉ 2026 StockFin.ai is not a SEBI-registered advisor. For informational purposes only.

Data provided by CMOTS Internet Technologies Pvt Ltd

AboutPrivacy PolicyTerms of ServicePricing

Latest News

View all โ†’
Axis Bank Ltd

Allotment of 116,086 shares under ESOP scheme

29 SeptAXISBANK
Read more โ†’
Sriven Multi-Tech Ltd

AGM approved FY2025-26 financials and reappointed Director V.S. Lalita.

29 Sept531536
Read more โ†’
Punjab National Bank

PNB participated in a virtual investor meeting hosted by Kotak Securities

29 SeptPNB
Read more โ†’
Indo Count Industries Ltd

Company announces plant visit for analysts and institutional investors

29 SeptICIL
Read more โ†’
Virya Resources Ltd

Virya Resources approved FY2026 financials and director changes at AGM

29 Sept512479
Read more โ†’
EP Biocomposites Ltd

Strategic collaboration with Malligavad Foundation announced

29 Sept543595
Read more โ†’
Oseaspre Consultants Ltd

Draft Letter of Offer submitted to SEBI for Oseaspre Consultants' open offer

29 Sept509782
Read more โ†’
National Securities Depository Ltd

CTO appointment and resignation announced

29 Sept544467
Read more โ†’
Digilogic Systems Ltd

Company announces virtual investor conference on September 30, 2026

29 Sept544684
Read more โ†’
Evexia Lifecare Ltd

Promoter group Shree Saibaba Exim acquired 42,42,111 shares of Evexia Lifecare on September 29, 2026.

29 Sept524444
Read more โ†’
Bharti Airtel Ltd

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requi

29 SeptBHARTIARTL
Read more โ†’
Cosmo First Ltd

Zigly Pet Care acquires Prolife Speciality Vet Clinic in Mumbai

29 SeptCOSMOFIRST
Read more โ†’
The Hi-Tech Gears Ltd

NCLAT extends interim stay on CIRP until October 5, 2026

29 SeptHITECHGEAR
Read more โ†’
Cosmo First Ltd

Cosmo First to acquire Prolife Speciality Vet Clinic LLP via slump sale

29 SeptCOSMOFIRST
Read more โ†’
Nuvoco Vistas Corporation Ltd

Bihar tax authority issues show cause notice over input tax credit dispute

29 SeptNUVOCO
Read more โ†’
Systematix Corporate Services Ltd

Cash investment of โ‚น10 crores via rights issue in wholly owned subsidiary

29 SeptSYSTMTXC
Read more โ†’
Aadhar Housing Finance Ltd

Timely interest payment confirmed for NCDs on September 29, 2026

29 SeptAADHARHFC
Read more โ†’
Arisinfra Solutions Ltd

ArisUnitern secures second Transcon mandate for โ‚น400 Cr Kalina project

29 SeptARIS
Read more โ†’
Mangalore Refinery And Petrochemicals Ltd

Fitch assigns first-time BBB- rating to MRPL with Stable outlook

29 SeptMRPL
Read more โ†’
Amara Raja Energy & Mobility Ltd

Virtual analyst and investor meeting scheduled for October 2, 2026

29 SeptARE&M
Read more โ†’